NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional)

The National Institute on Drug Abuse (NIDA) is announcing a funding opportunity as part of their Racial Equity Initiative (REI). This initiative, called Reaching Equity at the Intersection of HIV and Substance Use, allows the option for a clinical trial under the provision R34. Through REI, NIDA is aiming to eradicate racial inequities within its operations, staff and research programs.

The intent of this specific funding opportunity is to endorse preliminary or feasibility research. Particularly, NIDA is interested in studying the structural elements, practices within organizations, policies and several other sociocultural and contextual factors contributing to disparities. The focus areas of these disparities revolve around HIV and substance abuse among racial or ethnic groups that are consistently affected by HIV.

NIDA encourages studies that comprehensively examine the multiple aspects of a person's identity such as race, ethnicity, gender, sexual orientation, and gender identity. It also strongly recommends including an exploration of how these facets intersect with one another within social systems.